What is Sharon Klahre email address?

Sharon Klahre's primary email address is *******@syndax.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Sharon Klahre work for?

Sharon Klahre is a Vice President, Investor Relations and Corporate Communications at Syndax Pharmaceuticals, a company specializing in Commercial physical research.

Where Sharon Klahre graduated from?

Sharon Klahre holds a degree in from Lehigh University.

How can I directly contact Sharon Klahre?

To contact Sharon Klahre directly, you can use the email address *******@syndax.com. Complete contact information is available upon registration with Muraena.

Who is Sharon Klahre?

Sharon Klahre is an accomplished Vice President specializing in Investor Relations and Corporate Communications, currently at Syndax Pharmaceuticals. With over 20 years of experience in the biotechnology sector, she has a proven track record of building investor relations functions from the ground up, particularly in pre-IPO environments. Sharon has held key leadership roles at several notable firms, including Dewpoint Therapeutics and Spero Therapeutics, where she significantly contributed to strategic finance initiatives. Her academic background includes a B.S. in Biology and a Master's in Oriental Medicine, showcasing her diverse interests. Known for her exceptional communication skills, she effectively collaborates with senior management to craft compelling investor messaging. Sharon's career reflects a strong commitment to the biopharmaceutical industry, particularly in enhancing corporate visibility and stakeholder engagement.